Skip to main content
. 2020 Aug;8(16):1007. doi: 10.21037/atm-20-5332

Figure 1.

Figure 1

Inhibited SNHG22 could suppress the progression of ESCC cells. (A) Expression of SNHG22 was assessed in the human esophageal epithelial cell (HET-1A) and esophageal squamous cell carcinoma cells (Kyse-150, TE-10, and Eca109) via the qRT-PCR assay. (B) The inhibition efficiency of SNHG22 was verified by the qRT-PCR assay. (C,D) TE-10 and Eca109 cell proliferation were detected by CCK8 and colony formation assay. (E,F) Cell cycle progress and apoptosis of TE-10 and Eca109 cells are probed by flow cytometry analysis. (G,H) Cell autophagy of TE-10 and Eca109 cells was analyzed by immunofluorescence assay and western blot assay. **, P<0.01. SNHG22, small nucleolar RNA host gene 22; ESCC, esophageal squamous cell carcinoma; qRT-PCR, quantitative real-time PCR.